Today, Exxonmobil Investment Management Inc. TX Sold shares of Colgate-Palmolive Co. (CL)

Today, Exxonmobil Investment Management Inc. TX Sold shares of Colgate-Palmolive Co. (CL)
Exxonmobil Investment Management Inc. TX lowered its stake in Colgate-Palmolive Co. (NYSE:CL) by 1.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 227,630 shares of the company’s stock after selling 3,528 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Colgate-Palmolive were worth $16,876,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Krilogy Financial LLC raised its stake in Colgate-Palmolive by 3.2% in the second quarter. Krilogy Financial LLC now owns 1,504 shares of the company’s stock valued at $110,000 after buying an additional 46 shares in the last quarter. Tompkins Financial Corp raised its stake in Colgate-Palmolive by 121.1% in the second quarter. Tompkins Financial Corp now owns 1,698 shares of the company’s stock valued at $124,000 after buying an additional 930 shares in the last quarter. Arcadia Investment Management Corp MI raised its stake in Colgate-Palmolive by 28.6% in the second quarter. Arcadia Investment Management Corp MI now owns 1,800 shares of the company’s stock valued at $132,000 after buying an additional 400 shares in the last quarter. FCM Investments TX bought a new stake in Colgate-Palmolive during the second quarter valued at $132,000. Finally, Orrstown Financial Services Inc. raised its stake in Colgate-Palmolive by 26.7% in the second quarter. Orrstown Financial Services Inc. now owns 2,280 shares of the company’s stock valued at $167,000 after buying an additional 480 shares in the last quarter. Hedge funds and other institutional investors own 73.12% of the company’s stock.

Colgate-Palmolive Co. (NYSE:CL) traded up 0.82% during midday trading on Friday, hitting $66.53. The stock had a trading volume of 1,302,337 shares. The firm has a 50 day moving average of $69.86 and a 200 day moving average of $72.23. The firm has a market cap of $59.13 billion, a price-to-earnings ratio of 43.51 and a beta of 0.73. Colgate-Palmolive Co. has a 52 week low of $61.40 and a 52 week high of $75.38.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Thursday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.73. The business earned $3.87 billion during the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a return on equity of 6,924.14% and a net margin of 8.96%. The firm’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.80 earnings per share. Equities research analysts predict that Colgate-Palmolive Co. will post $2.82 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 15th. Shareholders of record on Monday, October 24th were issued a $0.39 dividend. The ex-dividend date of this dividend was Thursday, October 20th. This represents a $1.56 dividend on an annualized basis and a yield of 2.34%. Colgate-Palmolive’s dividend payout ratio (DPR) is 101.96%.

Several analysts have recently weighed in on CL shares. Citigroup Inc. lifted their price objective on shares of Colgate-Palmolive from $82.00 to $88.00 and gave the company a “buy” rating in a research note on Friday, July 29th. Bank of America Corp. upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $70.86 to $80.00 in a research note on Monday, September 12th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Monday, October 3rd. JPMorgan Chase & Co. reiterated a “hold” rating and issued a $75.00 price objective on shares of Colgate-Palmolive in a research note on Friday, July 29th. Finally, Wells Fargo & Co. reiterated a “market perform” rating on shares of Colgate-Palmolive in a research note on Tuesday, November 15th. Twelve analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $76.04.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,834 shares of the stock in a transaction on Monday, October 17th. The stock was sold at an average price of $72.39, for a total value of $277,543.26. Following the completion of the transaction, the insider now owns 55,013 shares in the company, valued at $3,982,391.07. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.05% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

Related posts

Leave a Comment